AstraZeneca is sued by Array BioPharma over cancer drug royalties

NEW YORK (Reuters) - Array BioPharma Inc on Thursday sued AstraZeneca AB, accusing the pharmaceutical company of refusing to pay required royalties for a cancer drug after entering into an $8.5 billion collaboration with Merck & Co.

from Reuters: Health News http://ift.tt/2nv84eE